Bio-Rad Laboratories (BIO) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free BIO Stock Alerts $277.09 +1.49 (+0.54%) (As of 02:11 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBio-Rad Announces Life Science Group Management Changesbusinesswire.com - April 26 at 8:30 AMS&P 500 (SPX) today: Top movers are Bio-Rad Laboratories Inc and Agilent Technologies, Inc.usatoday.com - April 23 at 3:09 PMBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Duality Advisers LPmarketbeat.com - April 22 at 11:54 AMKornitzer Capital Management Inc. KS Cuts Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 20 at 11:18 AMBio-Rad Laboratories (NYSE:BIO) Shares Gap Down to $290.86americanbankingnews.com - April 20 at 6:26 AMCommit To Purchase Bio-Rad Laboratories At $185, Earn 1.3% Annualized Using Optionsnasdaq.com - April 19 at 11:28 PMBio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024businesswire.com - April 18 at 9:00 AMBio-Rad Laboratories, Inc. (NYSE:BIO) Forecasted to Post Q1 2025 Earnings of $2.39 Per Shareamericanbankingnews.com - April 18 at 2:56 AMBio-Rad Laboratories, Inc. (NYSE:BIO) to Post Q1 2025 Earnings of $2.39 Per Share, Zacks Research Forecastsmarketbeat.com - April 17 at 5:55 PMZacks Research Weighs in on Bio-Rad Laboratories, Inc.'s Q1 2024 Earnings (NYSE:BIO)americanbankingnews.com - April 17 at 1:22 AMZacks Research Equities Analysts Reduce Earnings Estimates for Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 16 at 7:27 AMLecap Asset Management Ltd. Purchases New Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 13 at 8:08 PMRaymond James & Associates Sells 21,649 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 12 at 4:18 AMOncocyte, Bio-Rad Partner on Global Launch of Transplant Assaymarketwatch.com - April 11 at 6:28 PMOncocyte stock rallies 90% post-market on Bio-Rad partnershipseekingalpha.com - April 11 at 6:28 PMBio-Rad Laboratories (NYSE:BIO) Stock Price Down 3.9%marketbeat.com - April 11 at 1:48 PMAllspring Global Investments Holdings LLC Has $53.64 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 11 at 6:58 AMBio-Rad's Chief Operating Officer Andrew Last to Retirebusinesswire.com - April 10 at 4:15 PMBio-Rad Laboratories (NYSE:BIO) Downgraded by StockNews.com to "Hold"marketbeat.com - April 5 at 11:10 PMQ2 2024 Earnings Forecast for Bio-Rad Laboratories, Inc. Issued By Zacks Research (NYSE:BIO)marketbeat.com - April 4 at 8:49 AMGlobal Clinical Microbiology Market Size To Worth USD 6.58 Billion By 2033 | CAGR of 4.49%finance.yahoo.com - April 3 at 7:24 PMBio-Rad Laboratories (NYSE:BIO) Shares Gap Down to $328.72marketbeat.com - April 3 at 2:54 PMStocks Waver on Higher Bond Yields Ahead of Fed Chair Powellmsn.com - April 3 at 1:51 PMCitigroup Lowers Bio-Rad Laboratories (NYSE:BIO) to Neutralmarketbeat.com - April 3 at 8:24 AMBio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of "Buy" by Analystsmarketbeat.com - April 3 at 8:23 AMBio-Rad Laboratories, Inc. (NYSE:BIO) to Post Q1 2024 Earnings of $2.09 Per Share, Zacks Research Forecastsmarketbeat.com - April 3 at 6:00 AMBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Fifth Third Bancorpmarketbeat.com - April 3 at 5:18 AMBio-Rad Laboratories, Inc. (NYSE:BIO) Short Interest Up 15.1% in Marchmarketbeat.com - April 2 at 10:55 PMAssenagon Asset Management S.A. Has $4.07 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 2 at 4:38 AM25 Countries with Highest Malaria Death Ratesfinance.yahoo.com - March 31 at 4:48 PMGlobal Adult Hemoglobinopathy Testing Market to Reach $513.7 Million by 2030finance.yahoo.com - March 28 at 2:30 PMBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Nordea Investment Management ABmarketbeat.com - March 25 at 4:40 AMBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Vanguard Group Inc.marketbeat.com - March 21 at 4:45 AMBio-Rad Names Roop Lakkaraju Chief Financial Officermarketwatch.com - March 21 at 2:53 AMDeutsche Bank AG Decreases Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - March 19 at 4:41 AMThermo Fisher: Hold Rating Justified Amid Modest Growth Prospects and Full Valuationmarkets.businessinsider.com - March 18 at 2:36 PMBIO Apr 2024 340.000 callfinance.yahoo.com - March 17 at 11:34 PMShort Interest in Bio-Rad Laboratories, Inc. (NYSE:BIO) Drops By 14.3%marketbeat.com - March 16 at 11:19 AMComerica Bank Invests $11.05 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - March 15 at 5:00 AMLaser Capture Microdissection Market Worth $306 million | MarketsandMarketsfinanznachrichten.de - March 14 at 12:30 PMTudor Investment Corp Et Al Makes New Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - March 14 at 4:50 AMGlobal Syndromic Multiplex Panels Market Set for Rapid Expansion, Reveals New 2024-2028 Sector Forecastuk.finance.yahoo.com - March 12 at 1:28 PMGene Expression Analysis Market Worth $6.2 billion | MarketsandMarketsfinanznachrichten.de - March 12 at 1:28 PMPolar Capital Holdings Plc Buys 16,824 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - March 12 at 10:45 AMAnalysts Offer Insights on Healthcare Companies: Maravai Lifesciences Holdings (MRVI) and R1 RCM (RCM)markets.businessinsider.com - March 12 at 8:28 AMGlobal DNA Diagnostics Market Size To Worth USD 60.5 Billion By 2033 | CAGR Of 9.20%finance.yahoo.com - March 11 at 7:24 AMAQR Capital Management LLC Buys 21,651 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - March 9 at 6:00 AMBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Purchased by Sei Investments Co.marketbeat.com - March 7 at 8:42 AMBio-Rad Laboratories Q4 Earnings Transcriptmarketbeat.com - March 7 at 7:11 AMQuadrature Capital Ltd Raises Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - March 2 at 9:26 AM Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy BIO Media Mentions By Week BIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO News Sentiment▼0.440.33▲Average Medical News Sentiment BIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO Articles This Week▼75▲BIO Articles Average Week Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Waters News Illumina News Bio-Rad Laboratories News Revvity News 10x Genomics News Olink Holding AB (publ) News Avantor News ImmunoGen News Ascendis Pharma A/S News Penumbra News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
